
Dimerix inks lucrative US licensing deal for phase III drug candidate
Dimerix has entered an exclusive licensing deal for DMX-200 in the US. Pic viaGetty Images. Dimerix enters exclusive licence deal with Amicus Therapeutics to commercialise phase III drug candidate DMX-200 in US Deal is for focal segmental …